World Wide relies on analytics signals to operate securely and keep research services available. Accept to continue, or leave the site.
Review the Privacy Policy for details about analytics processing.
Dr
MIT, USA
Showing your local timezone
Schedule
Tuesday, February 16, 2021
10:30 AM America/New_York
Seminar location
No geocoded details are available for this content yet.
Recording provided by the organiser.
Format
Recorded Seminar
Recording
Available
Host
Timing Research Forum
Seminar location
No geocoded details are available for this content yet.
fMRI results have shown that the supplementary motor area (SMA) and the basal ganglia, most often discussed in their roles in generating action, are engaged by beat-based timing even in the absence of movement. Some have argued that the motor system is “recruited” by beat-based timing tasks due to the presence of motor-like timescales, but a deeper understanding of the roles of these motor structures is lacking. Reviewing a body of motor neurophysiology literature and drawing on the “active inference” framework, I argue that we can see the motor and timing functions of these brain areas as examples of dynamic sub-second prediction informed by sensory event timing. I hypothesize that in both cases, sub-second dynamics in SMA predict the progress of a temporal process outside the brain, and direct pathway activation in basal ganglia selects temporal and sensory predictions for the upcoming interval -- the only difference is that in motor processes, these predictions are made manifest through motor effectors. If we can unify our understanding of beat-based timing and motor control, we can draw on the substantial motor neuroscience literature to make conceptual leaps forward in the study of predictive timing and musical rhythm.
Jonathan Cannon
Dr
MIT, USA
neuro
neuro
The development of the iPS cell technology has revolutionized our ability to study development and diseases in defined in vitro cell culture systems. The talk will focus on Rett Syndrome and discuss t
neuro
Pluripotent cells, including embryonic stem (ES) and induced pluripotent stem (iPS) cells, are used to investigate the genetic and epigenetic underpinnings of human diseases such as Parkinson’s, Alzhe